George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSaga Regulatory News (SAGA)

Share Price Information for Saga (SAGA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 105.80
Bid: 106.60
Ask: 107.20
Change: 1.40 (1.34%)
Spread: 0.60 (0.563%)
Open: 107.20
High: 110.60
Low: 105.00
Prev. Close: 104.40
SAGA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

21 Dec 2023 15:44

RNS Number : 6748X
SAGA PLC
21 December 2023
 

21 December 2023

Directorate Change and Changes of Committee Membership

The Board of Saga announces that Eva Eisenschimmel, Non-Executive Director since 1 January 2019, is stepping down from the Board to allow her to completely focus on her executive role. Eva, who chairs the Remuneration Committee, is also a member of the Nomination Committee and the Board's People Champion, responsible for workforce engagement and ensuring that colleague views and opinions are communicated to the Board. She will leave the Board with effect from 31 December 2023.

The Company announces that Julie Hopes will become Chair of the Remuneration Committee and the Board's nominated People Champion. Anand Aithal, Gemma Godfrey and Gareth Hoskin will become members of the Nomination Committee. These changes take effect from 31 December 2023.

Following the changes above, the membership of the Company's Committees will be as follows:

Audit Committee:

Gareth Hoskin (Chair), Anand Aithal and Julie Hopes

 

Nomination Committee:

Sir Peter Bazalgette (Chair), Anand Aithal. Sir Roger De Haan, Gemma Godfrey and Gareth Hoskin

 

Remuneration Committee:

Julie Hopes (Chair), Sir Peter Bazalgette and Gemma Godfrey

 

Risk Committee:

Julie Hopes (Chair), Gemma Godfrey and Gareth Hoskin

 

Sir Roger De Haan, Non-Executive Chairman of Saga, said:

"I would like to thank Eva for all her hard work over the past five years. She has made a significant contribution to the Board, not least as our People Champion, ensuring that all directors have a deep understanding of the perspectives of our colleagues. We wish her well in her future endeavours."

Eva Eisenschimmel said:

"I hugely admire the Saga brand and its commitment to serving older people and it has been an honour to play a role via the Company's Board. I shall continue to be a cheerleader for Saga and its many brilliant people from outside the business and wish it the success it deserves."

 

 

For further information, please contact: 

Saga plc

 

Vicki Haynes, Company Secretary

Tel: 07803 602 139

Email: company.secretary@saga.co.uk

 

Emily Roalfe, Director of Investor Relations and Treasury

Tel: 07732 093 007

Email: emily.roalfe@saga.co.uk

 

Headland Consultancy

Susanna Voyle

Will Smith

Tel: 020 3805 4822

Tel: 07980 894 557

Tel: 07872 350 425

Email: saga@headlandconsultancy.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABUBDDXSDDGXB
Date   Source Headline
17th Apr 20247:00 amRNSPreliminary Results
30th Jan 20247:00 amRNSTrading Update
26th Jan 20247:00 amRNSResponse to Media Coverage
15th Jan 20244:52 pmRNSHolding(s) in Company
21st Dec 20234:43 pmRNSHolding(s) in Company
21st Dec 20234:39 pmRNSDirector/PDMR Shareholding
21st Dec 20233:44 pmRNSDirectorate Change
8th Dec 202312:53 pmRNSHolding(s) in Company
28th Nov 20237:00 amRNSDirectorate Change
20th Nov 20234:00 pmRNSHolding(s) in Company
2nd Nov 20232:44 pmRNSDirector/PDMR Shareholding
17th Oct 202311:53 amRNSHolding(s) in Company
9th Oct 20237:00 amRNSDirectorate Change
27th Sep 20237:01 amRNSDirectorate Change
27th Sep 20237:00 amRNSInterim Results
9th Aug 20234:47 pmRNSDirector/PDMR Shareholding
9th Aug 20234:44 pmRNSTotal Voting Rights
1st Aug 20233:03 pmRNSIssue of Equity
26th Jul 20238:37 amRNSChange of Registered Office
22nd Jun 20232:38 pmRNSHolding(s) in Company
20th Jun 20233:53 pmRNSResults of 2023 Annual General Meeting
20th Jun 20237:00 amRNSAGM Trading Update
13th Jun 20235:00 pmRNSDirector/PDMR Shareholding
30th May 20232:19 pmRNSDirector/PDMR Shareholding
15th May 20237:00 amRNSNotice of AGM
18th Apr 20237:00 amRNSAnnual Report and Accounts and Strategic Report
4th Apr 20237:00 amRNSPreliminary Results
2nd Mar 20239:10 amRNSTermination of discussions with Open Insurance
10th Feb 20237:00 amRNSResponse to Media Coverage
24th Jan 20237:01 amRNSCapital Markets Event
24th Jan 20237:00 amRNSTrading Update
23rd Jan 20237:00 amRNSResponse to Media Coverage
28th Dec 20227:00 amRNSHolding(s) in Company
14th Dec 20227:00 amRNSDirectorate Change
17th Nov 20222:47 pmRNSHolding(s) in Company
17th Nov 20229:00 amRNSEstablishment of New Committee
18th Oct 202210:15 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSDirector/PDMR Shareholding
27th Sep 20227:00 amRNSInterim Results
23rd Aug 20227:00 amRNSDirectorate Change
18th Jul 20225:08 pmRNSDirector/PDMR Shareholding
8th Jul 202210:50 amRNSDirector/PDMR Shareholding
5th Jul 20224:19 pmRNSResult of 2022 AGM
5th Jul 20227:00 amRNSDirectorate Change
5th Jul 20227:00 amRNSTrading Update
30th May 20229:00 amRNSNotice of 2022 AGM
3rd May 20225:04 pmRNSDirector/PDMR Shareholding
31st Mar 20224:29 pmRNSDirector/PDMR Shareholding
23rd Mar 20227:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.